Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00894517 · ClinicalTrials.gov registry record · Phase 1

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

A Phase 1 study of Benign Prostatic Hyperplasia, sponsored by Allergan.

Completed
Registry status
Phase 1
Development phase
61
Enrollment target
1
Study location

NCT00894517 is a Phase 1 study of Benign Prostatic Hyperplasia that has completed, run by Allergan. The registered enrollment target is 61 participants, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00894517, a Phase 1 study of Benign Prostatic Hyperplasia, has completed, sponsored by Allergan.

COMPLETED
Registry status
Phase 1
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • BIOLOGICAL Botulinum Toxin Type A
  • DRUG Placebo (saline)

Study Locations (1)

California

  • - Los Angeles

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2009-08
Est. Completion 2012-08
Phase Phase 1

Sponsor

Allergan

314 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00894517

The ClinicalTrials.gov registry entry for NCT00894517 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (89% lower). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Botulinum Toxin Type A is the first listed.

NCT00894517 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00894517 about?

NCT00894517 is a clinical study titled "A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia". This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

What is the current status of trial NCT00894517?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2009-08. Estimated completion is 2012-08.

What conditions does trial NCT00894517 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT00894517?

The interventions under investigation include: Botulinum Toxin Type A (BIOLOGICAL), Placebo (saline) (DRUG).

Who is sponsoring clinical trial NCT00894517?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00894517 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.